There’s never been a better time to be part of a biotech startup. We’re in the midst of a biological revolution that is opening near limitless possibilities for R&D innovation. We’ll set the stage for the day with Benchling’s outlook for startup companies in the biotechnology industry. You’ll hear what’s changed in the market for startups, how companies are going fast while also building for scale, and the pivotal role that digital solutions are playing in helping companies reach milestones faster.

A group of inspiring founders will share their stories on starting biotech ventures. They’ll offer perspectives on how they built their early teams and advisory boards, made platform and pipeline decisions, and navigated the current financing environment.

Hear from our panel of renowned venture capitalists as they share the top things they look for when backing early-stage biotech startups. Learn what they value in CEOs and founding teams, how they size up your market opportunities, and what they’ll look for in your R&D.

Setting the right R&D data strategy can help young companies move faster and ensure that their innovation will scale. In this session, you’ll hear from technology experts about how to use data to move faster and more effectively in R&D, including how to efficiently manage data, collaborate across teams, and analyze results to make smarter, quicker decisions.

Early-stage biotechs must make a range of initial decisions that impact their R&D strategy, corporate development, and team culture for years to come. In our final panel, you’ll hear from experts within the biotech ecosystem that have navigated these decisions and can share practical steps to take in your first year of development. 

Join us for an interactive session where you can ask questions from Benchling’s R&D experts as well as other leading technology providers. Get your questions answered and cover any additional topics you’d like to hear more on.